RBC Capital Reiterates Outperform on Biohaven, Maintains $59 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Leonid Timashev has reiterated an Outperform rating on Biohaven (NYSE:BHVN) and maintained a price target of $59.
June 18, 2024 | 12:29 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital has reiterated an Outperform rating on Biohaven and maintained a price target of $59, indicating continued confidence in the company's performance.
The reiteration of an Outperform rating and the maintenance of a $59 price target by RBC Capital suggests strong confidence in Biohaven's future performance. This positive analyst rating is likely to boost investor sentiment and could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100